CoChat

Clinical isolates of uncomplicated falciparum malaria from high and low malaria transmission areas show distinct pfcrt and pfmdr1 polymorphisms in western Ethiopia

Tadele, Geletta, Jawara, Aminata, Oboh, Mary, Oriero, Eniyou, Dugassa, Sisay, Amambua-Ngwa, Alfred, Golassa, Lemu · 2023 · Malaria Journal

Published version of a preprint

Cited by 12

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Background: Pfcrt gene has been associated with chloroquine resistance and the pfmdr1 gene can alter malaria parasite susceptibility to lumefantrine, mefloquine, and chloroquine. In the absence of chloroquine (CQ) and extensive use of artemether–lumefantrine (AL) from 2004 to 2020 to treat uncomplicated falciparum malaria, pfcrt haplotype, and pfmdr1 single nucleotide polymorphisms (SNPs) were determined in two sites of West Ethiopia with a gradient of malaria transmission. Methods: 230 microscopically confirmed P. falciparum isolates were collected from Assosa (high transmission area) and Gida Ayana (low transmission area) sites, of which 225 of them tested positive by PCR. High-Resolution Melting Assay (HRM) was used to determine the prevalence of pfcrt haplotypes and pfmdr1 SNPs. Furthermore, the pfmdr1 gene copy number (CNV) was determined using real-time PCR. A P -value of less or equal to 0.05 was considered significant. Results: Of the 225 samples, 95.5%, 94.4%, 86.7%, 91.1%, and 94.2% were successfully genotyped with HRM for pfcrt haplotype, pfmdr1 -86, pfmdr1 -184, pfmdr1 -1042 and pfmdr1 -1246, respectively. The mutant pfcrt haplotypes were detected among 33.5% (52/155) and 80% (48/60) of isolates collected from the Assosa and Gida Ayana sites, respectively. Plasmodium falciparum with chloroquine-resistant haplotypes was more prevalent in the Gida Ayana area compared with the Assosa area (COR = 8.4, P = 0.00). Pfmdr1 -N86Y wild type and 184F mutations were found in 79.8% (166/208) and 73.4% (146/199) samples, respectively. No single mutation was observed at the pfmdr1- 1042 locus; however, 89.6% (190/212) of parasites in West Ethiopia carry the wild-type D1246Y variants. Eight pfmdr1 haplotypes at codons N86Y–Y184F–D1246Y were identified with the dominant NFD 61% (122/200). There was no difference in the distribution of pfmdr1 SNPs, haplotypes, and CNV between the two study sites ( P > 0.05). Conclusion: Plasmodium falciparum with the pfcrt wild-type haplotype was prevalent in high malaria transmission site than in low transmission area. The NFD haplotype was the predominant haplotype of the N86Y–Y184F–D1246Y. A continuous investigation is needed to closely monitor the changes in the pfmdr1 SNPs, which are associated with the selection of parasite populations by ACT.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12936-023-04602-6

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 51

  1. Menard D, Dondorp A. Antimalarial drug resistance: a threat to malaria elimination. Cold Spring Harb Perspect. 2017;7:a025619. · DOI · Paper page
  2. Uwimana A, Legrand E, Stokes BH, Ndikumana JM, Warsame M, Umulisa N, et al. Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda. Nat Med. 2020;26:1602–8. · DOI · Paper page
  3. Tumwebaze PK, Conrad MD, Okitwi M, Orena S, Byaruhanga O, Katairo T, et al. Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda. Nat Commun. 2022;3:6353. · DOI
  4. Awasthi G, Krishna BK, Das A. Pfcrt haplotypes and the evolutionary history of chloroquine-resistant Plasmodium falciparum. Mem Inst Oswaldo Cruz. 2012;107:129–34. · doi:10.1590/s0074-02762012000100018
  5. Pelleau S, Moss EL, Dhingra SK, Volney B, Casteras J, Gabryszewski SJ, et al. Adaptive evolution of malaria parasites in French Guiana: reversal of chloroquine resistance by acquisition of a mutation in pfcrt. Proc Natl Acad Sci USA. 2015;112:11672–7. · DOI
  6. Kebede S, Aseffa A, Berhe N, Teklehaymanot T, Clouse RM, Gebru T, et al. Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia. Malar J. 2014;13:244. · DOI · Paper page
  7. Kishoyian G, Njagi EN, Orinda GO, Kimani FT. Chloroquine sensitivity and prevalence of chloroquine-resistant genes pfcrt and pfmdr-1 in Western Kenya after two decades of chloroquine withdrawal. Ann Med Health Sci. 2018;8:331–5.
  8. Omedo I, Bartilol B, Kimani D, Gonçalves S, Drury E, Rono MK, et al. Spatio-temporal distribution of antimalarial drug resistant gene mutations in a Plasmodium falciparum parasite population from Kilifi, Kenya: a 25-year retrospective study. Wellcome Open Res. 2022;7:1–21. · doi:10.12688/wellcomeopenres.17656.1
  9. Salissou A, Zamanka H, Binze BB, Rivière T, Tichit M, Ibrahim ML, et al. Low prevalence of pfcrt resistance alleles among patients with uncomplicated falciparum malaria in Niger six years after chloroquine withdrawal. Malar Res Treat. 2014;2014:614190.
  10. Kublin JG, Cortese JF, Njunju EM, Mukadam RA, Wirima JJ, Kazembe PN, et al. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J Infect Dis. 2003;187:1870–5. · DOI · Paper page
  11. Moyeh MN, Njimoh DL, Evehe MS, Ali IM, Nji AM, Nkafu DN, et al. Effects of drug policy changes on evolution of molecular markers of Plasmodium falciparum resistance to chloroquine, amodiaquine, and sulphadoxine-pyrimethamine in the South West Region of Cameroon. Malar Res Treat. 2018;2018:7071383.
  12. Golassa L, Enweji N, Erko B, Aseffa A, Swedberg G. High prevalence of pfcrt-CVIET haplotype in isolates from asymptomatic and symptomatic patients in south-central Oromia. Ethiopia Malar J. 2014;13:120. · doi:10.1186/1475-2875-13-120
  13. Golassa L, Kamugisha E, Ishengoma DS, Baraka V, Shayo A, Baliraine FN, et al. Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania. Malar J. 2015;14:264. · DOI
  14. Hassen J, Solomon G, Dinka H, Golassa L. High prevalence of Pfcrt76T and Pfmdr1 N86 genotypes in malaria infected patients attending health facilities in East Shewa zone, Oromia Regional State, Ethiopia. Malar J. 2022;21:286. · DOI · Paper page
  15. Hailemeskel E, Menberu T, Shumie G, Behaksra S, Chali W, Keffale M. Prevalence of Plasmodium falciparum Pfcrt and Pfmdr1 alleles in settings with different levels of Plasmodium vivax co-endemicity in Ethiopia. Int J Parasitol Drugs Drug Resist. 2019;11:8–12. · DOI · Paper page
  16. Roux AT, Maharaj L, Oyegoke O, Akoniyon OP, Adeleke MA, Maharaj R, et al. Chloroquine and sulfadoxine–pyrimethamine resistance in sub-Saharan Africa: a review. Front Genet. 2021;12:668574. · DOI
  17. Qidwai T. Exploration of copy number variation in genes related to anti-malarial drug resistance in Plasmodium falciparum. Gene. 2020;736:144414. · DOI
  18. Arya A, Kojom LP, Chaudhry S, Sharma A, Singh V. Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: a systematic review of clinical studies from two malaria endemic regions India and sub-Saharan Africa. Int J Parasitol Drugs Drug Resist. 2021;15:43–56. · DOI
  19. Ibraheem ZO, AbdMajid RA, Noor SM, Sedik HM, Basir R. Role of different Pfcrt and Pfmdr-1 mutations in conferring resistance to antimalaria drugs in Plasmodium falciparum. Malar Res Treat. 2014;2014:950424.
  20. Veiga MI, Dhingra SK, Henrich PP, Straimer J, Gnädig N, Uhlemann AC, et al. Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies. Nat Commun. 2016;7:11553. · DOI · Paper page
  21. Al-Mekhlafi HM, Madkhali AM, Ahmed A, Abdulhaq AA, Atroosh WM, Ghzwani AH, et al. Polymorphism analysis of pfmdr1gene in Plasmodium falciparum isolates 11 years post-adoption of artemisinin-based combination therapy in Saudi Arabia. Sci Rep. 2022;12:517. · doi:10.1038/s41598-021-04450-x
  22. Okell LC, Reiter LM, Ebbe LS, Baraka V, Bisanzio D, Watson OJ, et al. Emerging implications of policies on malaria treatment: genetic changes in the Pfmdr-1 gene affecting susceptibility to artemether–lumefantrine and artesunate–amodiaquine in Africa. BMJ Glob Health. 2018;3:e000999. · DOI · Paper page
  23. Achieng AO, Muiruri P, Ingasia LA, Opot BH, Juma DW, Yeda R, et al. Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya. Int J Parasitol Drugs Drug Resist. 2015;5:92–9. · DOI
  24. Thomsen TT, Madsen LB, Hansson HH, Tomás EV, Charlwood D, Bygbjerg IC, et al. Rapid selection of Plasmodium falciparum chloroquine resistance transporter gene and multidrug resistance gene-1 haplotypes associated with past chloroquine and present artemether–lumefantrine use in Inhambane District, Southern Mozambique. Am J Trop Med Hyg. 2013;88:536–41. · DOI
  25. Heuchert A, Abduselam N, Zeynudin A, Eshetu T, Loscher T, Wieser A, et al. Molecular markers of anti-malarial drug resistance in southwest Ethiopia over time: regional surveillance from 2006 to 2013. Malar J. 2015;14:208. · doi:10.1186/s12936-015-0723-2
  26. Shah NK, Alker AP, Sem R, Susanti AI, Muth S, Maguire JD, et al. Molecular surveillance for multidrug-resistant Plasmodium falciparum. Cambodia Emerg Infect Dis. 2008;14:1637–40. · doi:10.3201/eid1410.080080
  27. Srimuang K, Miotto O, Lim P, Fairhurst RM, Kwiatkowski DP, Woodrow CJ, et al. Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the tracking resistance to artemisinin collaboration. Malar J. 2016;15:541. · DOI
  28. Lim P, Alker AP, Khim N, Shah NK, Incardona S, Doung S, et al. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia. Malar J. 2009;8:11. · DOI · Paper page
  29. Ngalah BS, Ingasia LA, Cheruiyot AC, Chebon LJ, Juma DW, Muiruri P, et al. Analysis of major genome loci underlying artemisinin resistance and pfmdr1 copy number in pre- and post-ACTs in Western Kenya. Sci Rep. 2013;5:8308. · DOI
  30. Gadalla NB, Adam I, Elzaki S, Bashi S, Mukhtar I, Oguike M, et al. Increased pfmdr1 copy number and sequence polymorphisms in Plasmodium falciparum isolates from Sudanese malaria patients treated with artemether–lumefantrine. Antimicrob Agents Chemother. 2011;55:5408–11. · DOI
  31. Win AA, Imwong M, Kyaw MP, Woodrow CJ, Chotivanich K, Hanboonkunupakarn B, et al. K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar. Malar J. 2016;15:110. · DOI
  32. Labadie-Bracho M, Adhin MR. Increased pfmdr1 copy number in Plasmodium falciparum isolates from Suriname. Trop Med Int Health. 2013;18:796–9. · doi:10.1111/tmi.12118
  33. Pacheco C, Moreno J, Herrera F. A high number of pfmdr1 gene copies in P. falciparum from Venezuela. Parasitol Res. 2019;118:3085–9. · DOI
  34. Tajebe A, Aemero M, Francis K, Magoma G. Identification of chloroquine resistance Pfcrt-K76T and determination of Pfmdr1-N86Y copy number by SYBR Green I qPCR. Asian Pac J Trop Biomed. 2015;5:208–20. · doi:10.1016/s2221-1691(15)30008-3
  35. Taffese HS, Hemming-Schroeder E, Koepfli C, Tesfaye G, Lee MC, Kazura J, et al. Malaria epidemiology and interventions in Ethiopia from 2001 to 2016. Infect Dis Poverty. 2018;7:103. · DOI · Paper page
  36. Dufera M, Kenea O, Tadele G. Malaria incidence and associated risk factors in and around Anger Gute Town. Western Ethiopia Res Square. 2020. https://doi.org/10.21203/rs.3.rs-29458/v1. · doi:10.21203/rs.3.rs-29458/v1
  37. Simon N, Shallat J, Williams C, Harrington WE. Optimization of Chelex 100 resin-based extraction of genomic DNA from dried blood spots. Biol Methods Protoc. 2020;5:bpaa009. · DOI
  38. Daniels R, Ndiaye D, Wall M, McKinney J, Séne PD, Sabeti PC, et al. Rapid, field-deployable method for genotyping and discovery of single-nucleotide polymorphisms associated with drug resistance in Plasmodium falciparum. Antimicrob Agents Chemother. 2012;56:2976–86. · DOI
  39. Schunk M, Kumma WP, Miranda IB, Osman ME, Roewer S, Alano A, et al. High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia. Malar J. 2006;5:54. · DOI
  40. Lo E, Hemming-Schroeder E, Yewhalaw D, Nguyen J, Kebede E, Zemene E, et al. Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes. PLoS Negl Trop Dis. 2017;11:e0005806. · DOI
  41. Talisuna AO, Okello PE, Erhart A, Coosemans M, Alessandro UD. Intensity of malaria transmission and the spread of Plasmodium falciparum—resistant malaria: a review of epidemiologic field evidence. Am J Trop Med Hyg. 2007;77:170–80. · DOI
  42. Masserey T, Lee T, Golumbeanu M, Shattock AJ, Kelly SL, Hastings IM, et al. The influence of biological, epidemiological, and treatment factors on the establishment and spread of drug resistant Plasmodium falciparum. Elife. 2022;11:e77634. · DOI
  43. Jalousian F, Dalimi A, Samiee SM, Ghaffarifar F, Soleymanloo F, Naghizadeh R. Mutation in pfmdr1 gene in chloroquine-resistant Plasmodium falciparum isolates, Southeast Iran. Int J Infect Dis. 2008;12:630–4. · doi:10.1016/j.ijid.2008.01.004
  44. Gresty KJ, Gray K, Bobogare A, Taleo G, Hii J, Wini L, et al. Genetic mutations in pfcrt and pfmdr1 at the time of artemisinin combination therapy introduction in South Pacific islands of Vanuatu and Solomon Islands. Malar J. 2014;13:406. · DOI
  45. Plummer WB, Lexley LP, Carrington CV. Pfcrt and pfmdr1 alleles associated with Chloroquine resistance in Plasmodium falciparum from Guyana, South America. Mem Inst Oswaldo Cruz. 2004;99:389–92. · doi:10.1590/s0074-02762004000400008
  46. Sidhu AB, Valderramos SG, Fidock DA. Pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Mol Microbiol. 2005;57:913–26. · DOI
  47. Achol E, Ochaya S, Malinga GM, Edema H, Echodu R. High prevalence of Pfmdr1 N86 and D1246 genotypes detected among febrile malaria outpatients attending Lira Regional Referral Hospital, Northern Uganda. BMC Res Notes. 2019;12:235. · doi:10.1186/s13104-019-4269-1
  48. Voumbo-Matoumona DF, Kouna LC, Madamet M, Maghendji-Nzondo S, Pradines B, Lekana-Douki JB. Prevalence of Plasmodium falciparum antimalarial drug resistance genes in Southeastern Gabon from 2011 to 2014. Infect Drug Resist. 2018;11:1329–38. · DOI
  49. Duah NO, Matrevi SA, Souza DK, Binnah DD, Tamakloe MM, Opoku VS, et al. Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy. Malar J. 2013;12:377. · doi:10.1186/1475-2875-12-377
  50. Tadele G, Jaiteh FK, Oboh M, Oriero E, Dugassa S, Amambua-Ngwa A, et al. Persistence of residual submicroscopic P. falciparum parasitemia following treatment of artemether–lumefantrine in Ethio-Sudan Border, Western Ethiopia. Antimicrob Agents Chemother. 2022;66:e0000222. · DOI
  51. Chaisatit C, Sai-Ngam P, Thaloengsok S, Sriwichai S, Jongsakul K, Fukuda M, et al. Molecular detection of mutations in the propeller domain of kelch 13 and pfmdr1 copy number variation in Plasmodium falciparum isolates from Thailand collected from 2002 to 2007. Am J Trop Med Hyg. 2021;105:1093–6. · doi:10.4269/ajtmh.21-0303

Cited by

See all 12

Metadata

Authors
Tadele, G., Jawara, A., Oboh, M., Oriero, E., Dugassa, S., Amambua-Ngwa, A., & Golassa, L.
Venue
Malaria Journal
Published
2023-06-03
Volume
22
Issue
1
ISSN
1475-2875
Cited by
12
References
1
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical isolates of uncomplicated falciparum malaria from high and low malaria transmission areas show distinct pfcrt and pfmdr1 polymorphisms in western Ethiopia. https://app.cochat.ai/papers/10.1186/s12936-023-04602-6
The paper
Tadele, G., Jawara, A., Oboh, M., Oriero, E., Dugassa, S., Amambua-Ngwa, A., & Golassa, L. (2023). Clinical isolates of uncomplicated falciparum malaria from high and low malaria transmission areas show distinct pfcrt and pfmdr1 polymorphisms in western Ethiopia. Malaria Journal. https://doi.org/10.1186/s12936-023-04602-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.